25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BFNH (BioForce Nanosciences Holdings Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze BioForce Nanosciences Holdings Inc together

I guess you are interested in BioForce Nanosciences Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – BioForce Nanosciences Holdings Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – BioForce Nanosciences Holdings Inc’s Price Targets

I'm going to help you getting a better view of BioForce Nanosciences Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioForce Nanosciences Holdings Inc

I send you an email if I find something interesting about BioForce Nanosciences Holdings Inc.

1. Quick Overview

1.1. Quick analysis of BioForce Nanosciences Holdings Inc (30 sec.)










1.2. What can you expect buying and holding a share of BioForce Nanosciences Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$0.04
How sure are you?
21.6%

+ What do you gain per year?

Total Gains per Share
$0.05
Return On Investment
9.3%

For what price can you sell your share?

Current Price per Share
$0.54
Expected price per share
$0.4 - $0.55
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BioForce Nanosciences Holdings Inc (5 min.)




Live pricePrice per Share (EOD)
$0.54
Intrinsic Value Per Share
$0.01 - $0.02
Total Value Per Share
$0.00 - $0.01

2.2. Growth of BioForce Nanosciences Holdings Inc (5 min.)




Is BioForce Nanosciences Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$261.2k-$1.7m$64.9k3.8%

How much money is BioForce Nanosciences Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$120.6k-$118.1k-$2.5k-2.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of BioForce Nanosciences Holdings Inc (5 min.)




2.4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  


Richest
#438 / 458

Most Revenue
#457 / 458

Most Profit
#353 / 458

Most Efficient
#345 / 458
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BioForce Nanosciences Holdings Inc?

Welcome investor! BioForce Nanosciences Holdings Inc's management wants to use your money to grow the business. In return you get a share of BioForce Nanosciences Holdings Inc.

First you should know what it really means to hold a share of BioForce Nanosciences Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of BioForce Nanosciences Holdings Inc is $0.54. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BioForce Nanosciences Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BioForce Nanosciences Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BioForce Nanosciences Holdings Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.7%0.00-0.7%0.00-0.7%0.00-0.7%0.00-0.7%-0.13-24.0%
Usd Book Value Change Per Share0.0611.3%0.012.3%0.00-0.7%0.000.3%0.00-0.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0611.3%0.012.3%0.00-0.7%0.000.3%0.00-0.1%0.000.0%
Usd Price Per Share0.40-0.92-1.75-1.65-1.47-1.05-
Price to Earnings Ratio-27.22--65.37--124.82--116.56--102.45--274.11-
Price-to-Total Gains Ratio6.57--238.01--499.27--458.46--405.14--92.33-
Price to Book Ratio-51.33--25.82--33.30--40.24--73.36-503.85-
Price-to-Total Gains Ratio6.57--238.01--499.27--458.46--405.14--92.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.54
Number of shares1851
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (1851 shares)23.31-0.74
Gains per Year (1851 shares)93.25-2.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1093830-3-13
201871760-6-16
302802690-9-19
403733620-12-22
504664550-15-25
605605480-18-28
706536410-21-31
807467340-24-34
908398270-27-37
1009339200-30-40

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.036.00.02.7%2.050.00.03.8%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%8.029.00.021.6%10.042.00.019.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.037.00.0%4.00.048.07.7%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%8.029.00.021.6%10.042.00.019.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BioForce Nanosciences Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0610.013+383%-0.004+106%0.002+3240%0.000+101%0.000+100%
Book Value Per Share---0.008-0.051+551%-0.053+576%-0.047+507%-0.035+349%-0.019+139%
Current Ratio--0.0500.013+289%0.000+13353%0.005+856%0.037+37%6.232-99%
Debt To Asset Ratio--19.9321780.108-99%2705.152-99%1974.808-99%1197.801-98%647.571-97%
Debt To Equity Ratio----0%-0%-0%-0%0.266-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--13147478.00029234797.175-55%56980468.500-77%53700589.058-76%48105100.835-73%37914099.609-65%
Eps---0.004-0.004-2%-0.004-4%-0.004-3%-0.004-1%-0.130+3425%
Ev To Ebitda Ratio---26.688-230.215+763%-113.689+326%-165.894+522%-127.797+379%-333.366+1149%
Free Cash Flow Per Share--0.0000.000-3%0.000-32%0.000-13%0.000+2%0.000-20%
Free Cash Flow To Equity Per Share--0.0000.000+87%0.000+100%0.000+806%0.000+107%0.000+1291%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.017-2%1.009-1%
Intrinsic Value_10Y_max--0.016----------
Intrinsic Value_10Y_min--0.013----------
Intrinsic Value_1Y_max---0.001----------
Intrinsic Value_1Y_min---0.001----------
Intrinsic Value_3Y_max---0.001----------
Intrinsic Value_3Y_min---0.001----------
Intrinsic Value_5Y_max--0.001----------
Intrinsic Value_5Y_min--0.001----------
Market Cap18101772.000+26%13408720.00030936431.175-57%58746954.500-77%55287225.392-76%49279560.135-73%36492340.414-63%
Net Profit Margin----0%-0%-0%-0%-0.6380%
Operating Margin----0%-0%-0%-0%-0.6290%
Operating Ratio----0%-0%-0%-0%0.860-100%
Pb Ratio-69.291-35%-51.327-25.817-50%-33.296-35%-40.238-22%-73.360+43%503.846-110%
Pe Ratio-36.744-35%-27.218-65.369+140%-124.817+359%-116.555+328%-102.449+276%-274.112+907%
Price Per Share0.540+26%0.4000.923-57%1.753-77%1.649-76%1.470-73%1.051-62%
Price To Free Cash Flow Ratio-297.433-35%-220.321-541.977+146%-1637.864+643%-1246.661+466%-1032.991+369%-909.051+313%
Price To Total Gains Ratio8.872+26%6.572-238.006+3722%-499.267+7697%-458.459+7076%-405.140+6265%-92.326+1505%
Quick Ratio--0.0500.013+292%0.000+17486%0.005+867%0.036+41%5.516-99%
Return On Assets---8.925-99.502+1015%-180.884+1927%-136.947+1434%-84.413+846%-128.940+1345%
Return On Equity----0%-0%-0%-0%-586.2330%
Total Gains Per Share--0.0610.013+383%-0.004+106%0.002+3240%0.000+101%0.000+100%
Usd Book Value---261242.000-1701418.500+551%-1766326.500+576%-1586511.333+507%-1174219.650+349%-625018.838+139%
Usd Book Value Change Per Share--0.0610.013+383%-0.004+106%0.002+3240%0.000+101%0.000+100%
Usd Book Value Per Share---0.008-0.051+551%-0.053+576%-0.047+507%-0.035+349%-0.019+139%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--13147478.00029234797.175-55%56980468.500-77%53700589.058-76%48105100.835-73%37914099.609-65%
Usd Eps---0.004-0.004-2%-0.004-4%-0.004-3%-0.004-1%-0.130+3425%
Usd Free Cash Flow---15215.000-14721.000-3%-10307.250-32%-13217.917-13%-15494.500+2%-11897.568-22%
Usd Free Cash Flow Per Share--0.0000.000-3%0.000-32%0.000-13%0.000+2%0.000-20%
Usd Free Cash Flow To Equity Per Share--0.0000.000+87%0.000+100%0.000+806%0.000+107%0.000+1291%
Usd Market Cap18101772.000+26%13408720.00030936431.175-57%58746954.500-77%55287225.392-76%49279560.135-73%36492340.414-63%
Usd Price Per Share0.540+26%0.4000.923-57%1.753-77%1.649-76%1.470-73%1.051-62%
Usd Profit---123160.000-120696.000-2%-118190.250-4%-119888.000-3%-122010.800-1%-4341423.459+3425%
Usd Revenue----0%-0%-0%-0%832.676-100%
Usd Total Gains Per Share--0.0610.013+383%-0.004+106%0.002+3240%0.000+101%0.000+100%
 EOD+7 -1MRQTTM+17 -13YOY+17 -133Y+17 -135Y+19 -1210Y+20 -14

3.3 Fundamental Score

Let's check the fundamental score of BioForce Nanosciences Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-36.744
Price to Book Ratio (EOD)Between0-1-69.291
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.050
Current Ratio (MRQ)Greater than10.050
Debt to Asset Ratio (MRQ)Less than119.932
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-8.925
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of BioForce Nanosciences Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.663
Ma 20Greater thanMa 500.492
Ma 50Greater thanMa 1000.513
Ma 100Greater thanMa 2000.542
OpenGreater thanClose0.540
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About BioForce Nanosciences Holdings Inc

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

Fundamental data was last updated by Penke on 2025-06-27 08:25:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ BioForce Nanosciences Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ BioForce Nanosciences Holdings Inc to theΒ Packaged Foods industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-63.8%+63.8%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-3.5%
TTM-3.5%-3.5%
YOY-3.3%-3.3%
3Y-3.1%-3.1%
5Y-3.6%-3.6%
10Y-63.8%3.6%-67.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ BioForce Nanosciences Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ BioForce Nanosciences Holdings Inc to theΒ Packaged Foods industry mean.
  • -892.5% Return on Assets means thatΒ BioForce Nanosciences Holdings Inc generatedΒ $-8.93 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is -892.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9,950.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-892.5%TTM-9,950.2%+9,057.7%
TTM-9,950.2%YOY-18,088.4%+8,138.2%
TTM-9,950.2%5Y-8,441.3%-1,508.9%
5Y-8,441.3%10Y-12,894.0%+4,452.7%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-892.5%1.2%-893.7%
TTM-9,950.2%1.2%-9,951.4%
YOY-18,088.4%1.2%-18,089.6%
3Y-13,694.7%1.2%-13,695.9%
5Y-8,441.3%1.2%-8,442.5%
10Y-12,894.0%1.2%-12,895.2%
4.3.1.3. Return on Equity

Shows how efficient BioForce Nanosciences Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ BioForce Nanosciences Holdings Inc to theΒ Packaged Foods industry mean.
  • 0.0% Return on Equity means BioForce Nanosciences Holdings Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-58,623.3%+58,623.3%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%-2.6%
TTM-2.4%-2.4%
YOY-2.5%-2.5%
3Y-2.4%-2.4%
5Y-2.6%-2.6%
10Y-58,623.3%2.7%-58,626.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BioForce Nanosciences Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient BioForce Nanosciences Holdings Inc is operatingΒ .

  • Measures how much profit BioForce Nanosciences Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ BioForce Nanosciences Holdings Inc to theΒ Packaged Foods industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-62.9%+62.9%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.0%-5.0%
TTM-4.6%-4.6%
YOY-4.0%-4.0%
3Y-3.1%-3.1%
5Y-3.9%-3.9%
10Y-62.9%4.8%-67.7%
4.3.2.2. Operating Ratio

Measures how efficient BioForce Nanosciences Holdings Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Packaged Foods industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.860-0.860
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.539-1.539
TTM-1.425-1.425
YOY-1.090-1.090
3Y-1.206-1.206
5Y-1.142-1.142
10Y0.8601.059-0.199
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BioForce Nanosciences Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BioForce Nanosciences Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Packaged Foods industry mean).
  • A Current Ratio of 0.05Β means the company has $0.05 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.050. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.013. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.050TTM0.013+0.037
TTM0.013YOY0.000+0.013
TTM0.0135Y0.037-0.024
5Y0.03710Y6.232-6.195
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0501.525-1.475
TTM0.0131.517-1.504
YOY0.0001.570-1.570
3Y0.0051.605-1.600
5Y0.0371.644-1.607
10Y6.2321.664+4.568
4.4.3.2. Quick Ratio

Measures if BioForce Nanosciences Holdings Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ BioForce Nanosciences Holdings Inc to theΒ Packaged Foods industry mean.
  • A Quick Ratio of 0.05Β means the company can pay off $0.05 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.050. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.013. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.050TTM0.013+0.037
TTM0.013YOY0.000+0.013
TTM0.0135Y0.036-0.023
5Y0.03610Y5.516-5.480
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0500.525-0.475
TTM0.0130.534-0.521
YOY0.0000.662-0.662
3Y0.0050.662-0.657
5Y0.0360.682-0.646
10Y5.5160.774+4.742
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BioForce Nanosciences Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BioForce Nanosciences Holdings IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ BioForce Nanosciences Holdings Inc to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 19.93Β means that BioForce Nanosciences Holdings Inc assets areΒ financed with 1,993.2% credit (debt) and the remaining percentage (100% - 1,993.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 19.932. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1,780.108. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ19.932TTM1,780.108-1,760.176
TTM1,780.108YOY2,705.152-925.044
TTM1,780.1085Y1,197.801+582.307
5Y1,197.80110Y647.571+550.230
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ19.9320.469+19.463
TTM1,780.1080.476+1,779.632
YOY2,705.1520.474+2,704.678
3Y1,974.8080.479+1,974.329
5Y1,197.8010.483+1,197.318
10Y647.5710.484+647.087
4.5.4.2. Debt to Equity Ratio

Measures ifΒ BioForce Nanosciences Holdings Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ BioForce Nanosciences Holdings Inc to theΒ Packaged Foods industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.266-0.266
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.886-0.886
TTM-0.923-0.923
YOY-0.897-0.897
3Y-0.945-0.945
5Y-0.952-0.952
10Y0.2661.031-0.765
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings BioForce Nanosciences Holdings Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ BioForce Nanosciences Holdings Inc to theΒ Packaged Foods industry mean.
  • A PE ratio of -27.22 means the investor is paying $-27.22Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -36.744. Based on the earnings, the company is expensive. -2
  • The MRQ is -27.218. Based on the earnings, the company is expensive. -2
  • The TTM is -65.369. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-36.744MRQ-27.218-9.526
MRQ-27.218TTM-65.369+38.151
TTM-65.369YOY-124.817+59.447
TTM-65.3695Y-102.449+37.080
5Y-102.44910Y-274.112+171.662
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-36.74413.471-50.215
MRQ-27.21812.795-40.013
TTM-65.36912.667-78.036
YOY-124.81713.278-138.095
3Y-116.55514.833-131.388
5Y-102.44916.165-118.614
10Y-274.11218.889-293.001
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -297.433. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -220.321. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -541.977. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-297.433MRQ-220.321-77.112
MRQ-220.321TTM-541.977+321.656
TTM-541.977YOY-1,637.864+1,095.887
TTM-541.9775Y-1,032.991+491.014
5Y-1,032.99110Y-909.051-123.940
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-297.4335.235-302.668
MRQ-220.3214.911-225.232
TTM-541.9774.098-546.075
YOY-1,637.8643.866-1,641.730
3Y-1,246.6612.702-1,249.363
5Y-1,032.9911.509-1,034.500
10Y-909.0511.739-910.790
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ BioForce Nanosciences Holdings Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Packaged Foods industry mean).
  • A PB ratio of -51.33 means the investor is paying $-51.33Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -69.291. Based on the equity, the company is expensive. -2
  • The MRQ is -51.327. Based on the equity, the company is expensive. -2
  • The TTM is -25.817. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-69.291MRQ-51.327-17.964
MRQ-51.327TTM-25.817-25.510
TTM-25.817YOY-33.296+7.479
TTM-25.8175Y-73.360+47.543
5Y-73.36010Y503.846-577.206
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-69.2911.375-70.666
MRQ-51.3271.284-52.611
TTM-25.8171.393-27.210
YOY-33.2961.518-34.814
3Y-40.2381.637-41.875
5Y-73.3601.827-75.187
10Y503.8462.413+501.433
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets14
Total Liabilities275
Total Stockholder Equity-261
 As reported
Total Liabilities 275
Total Stockholder Equity+ -261
Total Assets = 14

Assets

Total Assets14
Total Current Assets14
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 14
Total Current Assets  (as reported)14
Total Current Assets  (calculated)14
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities275
Long-term Liabilities0
Total Stockholder Equity-261
Total Current Liabilities
Accounts payable 9
Other Current Liabilities 275
Total Current Liabilities  (as reported)275
Total Current Liabilities  (calculated)284
+/- 9
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock34
Retained Earnings -162,055
Other Stockholders Equity 161,760
Total Stockholder Equity (as reported)-261
Total Stockholder Equity (calculated)-261
+/-0
Other
Capital Stock34
Cash and Short Term Investments 14
Common Stock Shares Outstanding 32,247
Liabilities and Stockholders Equity 14
Net Debt -14
Net Invested Capital -261
Net Working Capital -261



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-302006-06-302006-03-312005-09-302005-06-30
> Total Assets 
0
0
6,500
5,936
5,390
4,120
3,529
3,192
3,091
2,579
2,306
2,197
21
21
20
20
19
18
18
18
16
16
15
16
14
13
12
21
23
24
29
35
41
47
53
59
51
43
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
1
2
1
14
14121111111191111272732404043515953474135292423211213141615161618181819202021212,1972,3062,5793,0913,1923,5294,1205,3905,9366,50000
   > Total Current Assets 
0
0
5,433
4,864
4,247
2,855
2,119
1,790
1,775
1,256
1,058
1,127
21
21
20
20
19
18
18
18
16
16
15
16
14
13
12
21
23
24
29
35
41
47
53
59
51
43
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
1
2
1
14
14121111111191111272732404043515953474135292423211213141615161618181819202021211,1271,0581,2561,7751,7902,1192,8554,2474,8645,43300
       Cash And Cash Equivalents 
0
0
5,356
4,467
3,631
1,504
762
552
269
58
56
12
21
21
20
20
19
0
18
18
16
16
15
14
14
13
12
14
19
24
24
29
35
41
47
53
47
40
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
1
2
1
14
1412111111119111127273240404047534741352924241914121314141516161818019202021211256582695527621,5043,6314,4675,35600
       Net Receivables 
0
0
16
14
9
247
272
6
314
207
128
269
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
0
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000006666605500000000000000026912820731462722479141600
       Other Current Assets 
0
0
6
66
48
56
116
102
146
91
55
77
21
0
0
20
0
18
0
18
0
0
0
2
14
13
0
2
4
0
0
0
0
0
0
6
5
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000035600000042013142000180180200021775591146102116564866600
   > Long-term Assets 
0
0
1,068
1,072
1,142
1,266
1,410
1,403
1,316
1,322
1,248
1,070
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000001,0701,2481,3221,3161,4031,4101,2661,1421,0721,06800
       Property Plant Equipment 
0
0
555
524
549
617
695
638
584
546
465
375
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000037546554658463869561754952455500
       Intangible Assets 
0
0
513
548
593
649
715
764
732
777
783
675
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000067578377773276471564959354851300
> Total Liabilities 
41
43
630
603
621
784
1,009
1,051
858
917
1,331
1,703
0
0
0
1
1
1
1
1
1
1
1
14
1
1
1
13
9
8
5
5
7
5
5
12
44
162
277
400
537
655
769
873
1,005
1,119
1,233
1,348
1,478
1,592
1,706
1,820
1,951
2,065
2,180
2,302
275
2752,3022,1802,0651,9511,8201,7061,5921,4781,3481,2331,1191,005873769655537400277162441255755891311114111111110001,7031,3319178581,0511,0097846216036304341
   > Total Current Liabilities 
41
43
186
171
226
530
798
891
703
774
1,193
1,588
0
0
0
1
1
1
1
1
1
1
1
14
1
1
1
13
9
8
5
5
7
5
5
12
44
162
277
400
537
655
769
873
1,005
1,119
1,233
1,348
1,478
1,592
1,706
1,820
1,951
2,065
2,180
2,302
275
2752,3022,1802,0651,9511,8201,7061,5921,4781,3481,2331,1191,005873769655537400277162441255755891311114111111110001,5881,1937747038917985302261711864341
       Short-term Debt 
0
0
878
0
26
145
238
109
89
73
296
719
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
34
47
56
0
0
0
0
0
0
157
165
174
197
206
214
0
238
252
0
0
0
0002522380214206197174165157000000564734000000000111100000000000719296738910923814526087800
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
34
47
56
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000564734000000000111100000000000000000000000
       Accounts payable 
4
3
150
163
200
162
247
318
305
418
543
506
0
0
0
1
0
1
1
1
1
1
1
14
1
1
1
13
9
8
5
5
7
5
5
10
1
0
0
5
12
1
0
6
0
0
1
0
2
1
1
3
10
5
6
9
9
9965103112010060112500110557558913111141111110100050654341830531824716220016315034
       Other Current Liabilities 
38
39
36
8
0
198
257
422
255
246
311
331
0
0
0
0
1
-1
0
0
0
0
0
0
-1
-1
0
0
13
8
0
5
7
5
5
1
10
115
221
395
525
654
768
867
1,005
1,119
1,232
1,348
1,476
1,591
1,704
0
1,941
2,060
2,174
0
275
27502,1742,0601,94101,7041,5911,4761,3481,2321,1191,0058677686545253952211151015575081300-1-1000000-11000033131124625542225719808363938
   > Long-term Liabilities 
0
0
444
433
395
255
211
159
155
144
138
115
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
0
0
0
0
000000002010000000000000000000000-10000000000011513814415515921125539543344400
> Total Stockholder Equity
-41
-43
5,870
5,333
4,769
3,336
2,520
2,142
2,233
1,661
975
495
21
20
20
19
19
36
17
-16
16
15
15
-21
-63
-423
12
8
14
16
24
30
34
42
48
47
7
-119
-237
-360
-505
-627
-741
-862
-994
-1,110
-1,233
-1,347
-1,477
-1,591
-1,705
-1,819
-1,950
-2,064
-2,178
-2,302
-261
-261-2,302-2,178-2,064-1,950-1,819-1,705-1,591-1,477-1,347-1,233-1,110-994-862-741-627-505-360-237-11974748423430241614812-423-63-21151516-16173619192020214959751,6612,2332,1422,5203,3364,7695,3335,870-43-41
   Common Stock
2
2
24
24
24
24
24
24
25
25
13
25
0
0
0
0
0
0
0
0
0
36
36
76
76
76
76
76
76
76
76
76
76
76
76
15
15
15
15
29
29
29
29
29
29
29
29
29
29
29
29
0
29
29
29
0
34
34029292902929292929292929292929291515151576767676767676767676767636360000000002513252524242424242422
   Retained Earnings 
-376
-378
-6,000
0
-8,600
-11,086
-11,915
-13,548
-14,135
-14,891
-15,815
-16,506
21
20
20
0
0
0
0
-16
0
-21
-21
-616
-63
-423
-623
-647
-671
-700
-707
-715
-728
-735
-742
-762
-158,803
-158,930
-159,048
-159,170
-159,315
-159,438
-159,552
-159,672
-159,805
-159,920
-160,043
-160,158
-160,288
-160,402
-160,515
-160,630
-160,761
-160,875
-160,997
-161,120
-162,055
-162,055-161,120-160,997-160,875-160,761-160,630-160,515-160,402-160,288-160,158-160,043-159,920-159,805-159,672-159,552-159,438-159,315-159,170-159,048-158,930-158,803-762-742-735-728-715-707-700-671-647-623-423-63-616-21-210-160000202021-16,506-15,815-14,891-14,135-13,548-11,915-11,086-8,6000-6,000-378-376
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
158,781
0
158,781
158,781
0
0
0
0
0
0
0
0
0
0
0000000000158,781158,7810158,7810000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
332
333
11,847
5,309
13,344
14,398
14,668
15,665
17,231
16,531
16,796
16,999
0
0
0
19
19
36
17
17
16
0
0
519
0
0
558
0
609
640
654
745
686
701
714
794
158,793
158,793
158,793
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
0
158,781
158,781
158,789
0
161,760
161,7600158,789158,781158,7810158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,793158,793158,7937947147016867456546406090558005190016171736191900016,99916,79616,53117,23115,66514,66814,39813,3445,30911,847333332



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-67
Operating Income-490-67
 
Operating Expense (+$)
Research Development0
Selling General Administrative67
Selling And Marketing Expenses0
Operating Expense6767
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-490
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-490-490
EBIT - interestExpense = 0
-490
-490
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-490
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-490
Tax Provision-0
Net Income From Continuing Ops-490-490
Net Income-490
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of BioForce Nanosciences Holdings Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BioForce Nanosciences Holdings Inc. The general trend of BioForce Nanosciences Holdings Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BioForce Nanosciences Holdings Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. BioForce Nanosciences Holdings Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioForce Nanosciences Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.55 < 0.55 < 0.55.

The bearish price targets are: 0.4 > 0.4 > 0.4.

Know someone who trades $BFNH? Share this with them.πŸ‘‡

BioForce Nanosciences Holdings Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioForce Nanosciences Holdings Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioForce Nanosciences Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioForce Nanosciences Holdings Inc. The current macd is -0.01086237.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BioForce Nanosciences Holdings Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for BioForce Nanosciences Holdings Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the BioForce Nanosciences Holdings Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BioForce Nanosciences Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioForce Nanosciences Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioForce Nanosciences Holdings Inc. The current adx is 47.92.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell BioForce Nanosciences Holdings Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
BioForce Nanosciences Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioForce Nanosciences Holdings Inc. The current sar is 0.4001.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
BioForce Nanosciences Holdings Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioForce Nanosciences Holdings Inc. The current rsi is 58.66. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
BioForce Nanosciences Holdings Inc Daily Relative Strength Index (RSI) ChartBioForce Nanosciences Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioForce Nanosciences Holdings Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BioForce Nanosciences Holdings Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BioForce Nanosciences Holdings Inc Daily Stochastic Oscillator ChartBioForce Nanosciences Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioForce Nanosciences Holdings Inc. The current cci is 91.08.

BioForce Nanosciences Holdings Inc Daily Commodity Channel Index (CCI) ChartBioForce Nanosciences Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioForce Nanosciences Holdings Inc. The current cmo is 29.20.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BioForce Nanosciences Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartBioForce Nanosciences Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioForce Nanosciences Holdings Inc. The current willr is -6.67111408.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
BioForce Nanosciences Holdings Inc Daily Williams %R ChartBioForce Nanosciences Holdings Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioForce Nanosciences Holdings Inc. The current atr is 0.03102217.

BioForce Nanosciences Holdings Inc Daily Average True Range (ATR) ChartBioForce Nanosciences Holdings Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioForce Nanosciences Holdings Inc. The current obv is 138,428.

BioForce Nanosciences Holdings Inc Daily On-Balance Volume (OBV) ChartBioForce Nanosciences Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioForce Nanosciences Holdings Inc. The current mfi is 91.41.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
BioForce Nanosciences Holdings Inc Daily Money Flow Index (MFI) ChartBioForce Nanosciences Holdings Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioForce Nanosciences Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

BioForce Nanosciences Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioForce Nanosciences Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.663
Ma 20Greater thanMa 500.492
Ma 50Greater thanMa 1000.513
Ma 100Greater thanMa 2000.542
OpenGreater thanClose0.540
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BioForce Nanosciences Holdings Inc with someone you think should read this too:
  • Are you bullish or bearish on BioForce Nanosciences Holdings Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BioForce Nanosciences Holdings Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioForce Nanosciences Holdings Inc

I send you an email if I find something interesting about BioForce Nanosciences Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioForce Nanosciences Holdings Inc.

Receive notifications about BioForce Nanosciences Holdings Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.